Literature DB >> 27100754

The state of the science of whole blood: lessons learned at Mayo Clinic.

James R Stubbs1, Martin D Zielinski2, Donald Jenkins2.   

Abstract

AABB Standards specify that ABO group-specific whole blood is the only acceptable choice for whole blood transfusions. Although universal donor group O stored whole blood (SWB) was used extensively by the military during the wars of the mid-twentieth century, its use has fallen out of favor and has never been used to great extent in the civilian trauma population. Interest in the use of whole blood has been renewed, particularly in light of its potential value in far-forward military and other austere environments. Evidence of preserved platelet function in SWB has heightened enthusiasm for a "one stop shop" resuscitation product providing volume, oxygen carrying capacity, and hemostatic effects. Experience with universal donor group O SWB is required to ascertain whether its use will be an advance in trauma care. Described here is the process of establishing a universal donor group O SWB at a civilian trauma center in the United States.
© 2016 AABB.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27100754      PMCID: PMC4882089          DOI: 10.1111/trf.13501

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  Blood usage in rotor-wing transport.

Authors:  K S Berns; S P Zietlow
Journal:  Air Med J       Date:  1998 Jul-Sep

2.  A CLINICAL STUDY OF TRANSFUSION REACTIONS: THE HEMOLYTIC EFFECT OF GROUP-O BLOOD AND POOLED PLASMA CONTAINING INCOMPATIBLE ISOAGGLUTININS.

Authors:  R V Ebert; C P Emerson
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

3.  Coagulation function of stored whole blood is preserved for 14 days in austere conditions: A ROTEM feasibility study during a Norwegian antipiracy mission and comparison to equal ratio reconstituted blood.

Authors:  Geir Strandenes; Ivar Austlid; Torunn O Apelseth; Tor A Hervig; Jan Sommerfelt-Pettersen; Maryanne C Herzig; Andrew P Cap; Heather F Pidcoke; Einar K Kristoffersen
Journal:  J Trauma Acute Care Surg       Date:  2015-06       Impact factor: 3.313

4.  Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009.

Authors:  Philip C Spinella; Alex Dressler; Marisa Tucci; Christopher L Carroll; Rosa Sanchez Rosen; Heather Hume; Steven R Sloan; Jacques Lacroix
Journal:  Transfusion       Date:  2010-11       Impact factor: 3.157

Review 5.  Status of the use of universal donor blood transfusion.

Authors:  A Barnes
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1973-08

Review 6.  Transfusion of universal donor and uncrossmatched blood.

Authors:  A Barnes
Journal:  Bibl Haematol       Date:  1980

7.  The effects of prehospital plasma on patients with injury: a prehospital plasma resuscitation.

Authors:  Brian D Kim; Martin D Zielinski; Donald H Jenkins; Henry J Schiller; Kathleen S Berns; Scott P Zietlow
Journal:  J Trauma Acute Care Surg       Date:  2012-08       Impact factor: 3.313

8.  Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time.

Authors:  Heather F Pidcoke; Steve J McFaul; Anand K Ramasubramanian; Bijaya K Parida; Alex G Mora; Chriselda G Fedyk; Krystal K Valdez-Delgado; Robbie K Montgomery; Kristin M Reddoch; Armando C Rodriguez; James K Aden; John A Jones; Ron S Bryant; Michael R Scherer; Heather L Reddy; Raymond P Goodrich; Andrew P Cap
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

9.  A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions.

Authors:  Bryan A Cotton; Jeanette Podbielski; Elizabeth Camp; Timothy Welch; Deborah del Junco; Yu Bai; Rhonda Hobbs; Jamie Scroggins; Beth Hartwell; Rosemary A Kozar; Charles E Wade; John B Holcomb
Journal:  Ann Surg       Date:  2013-10       Impact factor: 12.969

  9 in total
  6 in total

Review 1.  Remote Damage Control Resuscitation in Austere Environments.

Authors:  Ronald Chang; Brian J Eastridge; John B Holcomb
Journal:  Wilderness Environ Med       Date:  2017-06       Impact factor: 1.518

2.  The use of whole blood in traumatic bleeding: a systematic review.

Authors:  Mario Cruciani; Massimo Franchini; Carlo Mengoli; Giuseppe Marano; Ilaria Pati; Francesca Masiello; Eva Veropalumbo; Simonetta Pupella; Stefania Vaglio; Vanessa Agostini; Giancarlo Maria Liumbruno
Journal:  Intern Emerg Med       Date:  2020-09-15       Impact factor: 3.397

Review 3.  Whole Blood, Fixed Ratio, or Goal-Directed Blood Component Therapy for the Initial Resuscitation of Severely Hemorrhaging Trauma Patients: A Narrative Review.

Authors:  Mark Walsh; Ernest E Moore; Hunter B Moore; Scott Thomas; Hau C Kwaan; Jacob Speybroeck; Mathew Marsee; Connor M Bunch; John Stillson; Anthony V Thomas; Annie Grisoli; John Aversa; Daniel Fulkerson; Stefani Vande Lune; Lucas Sjeklocha; Quincy K Tran
Journal:  J Clin Med       Date:  2021-01-17       Impact factor: 4.241

4.  Back to the Future: Whole Blood Resuscitation of the Severely Injured Trauma Patient.

Authors:  Christopher Cameron McCoy; Megan Brenner; Juan Duchesne; Derek Roberts; Paula Ferrada; Tal Horer; David Kauvar; Mansoor Khan; Andrew Kirkpatrick; Carlos Ordonez; Bruno Perreira; Artai Priouzram; Bryan A Cotton
Journal:  Shock       Date:  2021-12-01       Impact factor: 3.454

5.  Transfusion: -80°C Frozen Blood Products Are Safe and Effective in Military Casualty Care.

Authors:  Femke Noorman; Thijs T C F van Dongen; Marie-Christine J Plat; John F Badloe; John R Hess; Rigo Hoencamp
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

Review 6.  Hemorrhagic Resuscitation Guided by Viscoelastography in Far-Forward Combat and Austere Civilian Environments: Goal-Directed Whole-Blood and Blood-Component Therapy Far from the Trauma Center.

Authors:  James H Lantry; Phillip Mason; Matthew G Logsdon; Connor M Bunch; Ethan E Peck; Ernest E Moore; Hunter B Moore; Matthew D Neal; Scott G Thomas; Rashid Z Khan; Laura Gillespie; Charles Florance; Josh Korzan; Fletcher R Preuss; Dan Mason; Tarek Saleh; Mathew K Marsee; Stefani Vande Lune; Qamarnisa Ayoub; Dietmar Fries; Mark M Walsh
Journal:  J Clin Med       Date:  2022-01-12       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.